-
Afatinib, sold
under the
brand name
Gilotrif among others, is a
medication which is used to
treat non-small cell lung
carcinoma (NSCLC). It
belongs to...
-
approved afatinib, a drug
developed by
Boehringer Ingelheim, as an irreversible,
competitive inhibitor of HER2 and EGFR kinases.
While afatinib demonstrates...
- sofosbuvir/daclatasvir, osimertinib, crizotinib, daclatasvir, sofosbuvir,
afatinib, axitinib, brigatinib, baricitinib, cabozantinib, dasatinib, neratinib...
- (ipratropium
bromide / salbutamol)
Cosela (trilaciclib)
Gilotrif /
Giotrif (
afatinib)
Jardiance (empagliflozin)
Jentadueto /
TrajentaDuo (linagliptin / metformin)...
-
objective response rate with
median progression free
survival of 6.1
months Afatinib: 10%
objective response rate with
median progression free
survival of 8...
-
afalanine (INN)
afamelanotide (INN)
afamitresgene autoleucel (USAN, INN)
afatinib (INN, (USAN)
Afaxin a****ostat (USAN, INN)
afelimomab (INN) afimoxifene...
-
other EGFR
tyrosine kinase inhibitors, such as gefitinib, erlotinib, and
afatinib. In the US, EGFR exon 19 deletions, exon 21 L858R mutations, or the T790M...
- can be
treated with EGFR
inhibitors osimertinib, erlotinib, gefitinib,
afatinib, or
dacomitinib – with
osimertinib known to be
superior to
erlotinib and...
- EGFR (called "EGFR inhibitors", EGFRi),
including gefitinib, erlotinib,
afatinib,
brigatinib and
icotinib for lung cancer, and
cetuximab for
colon cancer...
-
Ponatinib L01EA06
Asciminib L01EB01
Gefitinib L01EB02
Erlotinib L01EB03
Afatinib L01EB04
Osimertinib L01EB05
Rociletinib L01EB06
Olmutinib L01EB07 Dacomitinib...
